HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
about
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a reviewChallenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell countHigh interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.Effectiveness and safety of oral HIV preexposure prophylaxis for all populationsAn application of propensity score weighting to quantify the causal effect of rectal sexually transmitted infections on incident HIV among men who have sex with men.Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role.Emerging themes for sensitivity training modules of African healthcare workers attending to men who have sex with men: a systematic review.The Effect of High Rates of Bacterial Sexually Transmitted Infections on HIV Incidence in a Cohort of Black and White Men Who Have Sex with Men in Atlanta, GeorgiaDefining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigmPre-exposure prophylaxis in Southern Africa: feasible or not?Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.Contributions of Qualitative Research in Informing HIV/AIDS Interventions Targeting Black MSM in the United States.Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender WomenHIV Incidence Among Men Who Have Sex With Men After Diagnosis With Sexually Transmitted Infections.Differences in Attitudes About HIV Pre-Exposure Prophylaxis Use Among Stimulant Versus Alcohol Using Men Who Have Sex with Men.Statistical issues in trials of preexposure prophylaxis.The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African WomenTransgender populations and HIV: unique risks, challenges and opportunities.Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender PeopleRegular STI testing amongst men who have sex with men and use social media is suboptimal - a cross-sectional study.Plasma Tenofovir-levels to Support Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.Distribution of Behavioral Patterns Before Infection Among San Francisco Men Who Have Sex With Men Newly Infected With HIV in 2014.Is Sex with Older Male Partners Associated with Higher Sexual Risk Behavior Among Young Black MSM?Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men.Project LifeSkills - a randomized controlled efficacy trial of a culturally tailored, empowerment-based, and group-delivered HIV prevention intervention for young transgender women: study protocol.PrEP Implementation Science: State-of-the-Art and Research Agenda.Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.Using Contact Patterns to Inform HIV Interventions in Persons Who Inject Drugs in Northern Vietnam.Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis.Accuracy of HIV Risk Perceptions Among Episodic Substance-Using Men Who Have Sex with Men.Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?Recent advances in pre-exposure prophylaxis for HIV.
P2860
Q26849762-C1B03305-1CE4-41BB-97C1-53A881BD3D49Q27318314-3B0FCA8D-E454-4200-A610-4D5D026E915EQ30877918-E410463A-5A1C-4DA4-9747-A8DE00A01465Q34202159-B351DCD6-572E-47C0-A1EC-E0D345E62972Q34677217-13DFBF1D-F807-4050-BE72-94C1E625D758Q35205206-780D08A9-5615-4AF7-80AC-239678752666Q35558232-F61B522C-BF7D-4370-AE33-2D4D5591B8A6Q35575958-A12770FD-2B0F-41C0-BB9B-B7DB66E41E48Q35593824-7D28FF60-876D-4124-9768-512464CE6298Q35692172-33FA8538-A227-4892-8FB1-3AF00A96910FQ35780443-22D0A743-CC65-4207-A086-D4B5B835677AQ35875719-A2857415-B95E-42E4-8104-14493C7664CCQ36426896-A4EA2FFB-201C-4123-A523-F48B821928FAQ36487836-B4CEA9FF-39FC-4164-B159-47468EA489B1Q36540831-FAEA2DC3-B02B-4AD0-A7C3-4E2A49C8D710Q36619611-8112DD29-A9D9-4C80-9F73-D251E10EF639Q36649885-15A7D95A-9D00-4A1C-BF0A-004195F0D375Q36682112-0057F6E6-5E7A-4DFA-9765-55327EE5B560Q36803999-36F1CB4C-121B-450C-8F34-180353E750E3Q36818077-AF59E3BD-EB61-4303-B458-9EC4019B247AQ36988613-B9198C95-1527-46D8-B10B-FD77FB0B7902Q36994977-63DC598A-13C0-4C91-A7B0-AB5E829A84F9Q37014243-F7E3715A-F187-419A-9C2B-F3AB45C73360Q37136266-0F331672-365A-478A-8942-E8073913B834Q37143385-00648EB5-D3E4-48EA-914E-CB4920719144Q37143388-ADCB6C44-9643-4A91-8E4F-EEF024D752FBQ39946045-424218E8-0AEB-4A06-9497-994BC5B14D07Q40049420-49865EF8-8B5C-430A-A60C-DDE024A197DDQ40210908-7693199F-4BF2-4901-892E-212C4A2F69CCQ40350907-D14FF39A-6FDE-4B84-ACDD-6DFCA42F7CFCQ40612877-6D8ED5EC-581D-45B6-A684-B783268EDCABQ41077832-EC6C0863-3B4C-40B2-A568-63319AD8953FQ41712145-894609AC-B3AB-418B-8E52-46C1701F8571Q43241737-134C178D-018A-4569-830A-BB4EDCA35DE6Q45999968-1A7EB683-4991-4C24-A23C-FF3AAADA0C66Q47553576-1904DAA2-32CD-4FF8-8DF1-6EC5A2C60969Q47580343-B6E7B9D1-2D63-4BEB-A50F-ACF27540CEB4Q47627546-D3AB66C7-75A1-448D-8467-D915882F2C78Q49182406-E0A17C80-D530-4D6A-9679-8467D0B76030Q49921922-6F7EDC23-AEAE-4745-B836-1001C9D5577C
P2860
HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@ast
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@en
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@nl
type
label
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@ast
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@en
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@nl
prefLabel
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@ast
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@en
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@nl
P2093
P2860
P50
P1476
HIV pre-exposure prophylaxis i ...... sed controlled efficacy trial.
@en
P2093
Albert Y Liu
David V Glidden
Pedro Goicochea
Susan P Buchbinder
Vanessa McMahan
P2860
P304
P356
10.1016/S1473-3099(14)70025-8
P577
2014-03-07T00:00:00Z